The FDA has given consent to a software product from an AI startup that is directed at making it uncomplicated for doctors to take ultrasound images of the heart.
It is to be noted that the aforementioned technology will probably aid more hospitals use the diagnostic test, which presently necessitates proficiency that is inadequate.
The deputy director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health, Robert Ochs mentioned that today’s marketing authorization allows medical specialists who might not be specialists in ultrasonography to use the tool. These medical staff include a registered nurse in a family care clinic or other medical professionals. He further added that this is particularly significant as it establishes the potential for AI and machine learning technologies to improve admittance to harmless cardiac diagnostics that can be life-saving for several patients.
Furthermore, the Food and Drug Administration approved the software through a process used for brand new medical devices known as Caption Guidance. Even though the aforementioned software supports medical experts attain the echocardiogram image, a trained cardiologist still undergoes the images in order to do detailed analysis.
What is your opinion about the increasing use of AI in medical diagnosis of heart related diseases? Let us know in the comments below!
The Future is Now Media Group have launched a YouTube show called The Future is Now Digest, hosted by Miguel Francis-Santiago. Together […]
April 30, 2020
PRESS RELEASE — 10,000 participants are expected to join CHAIN2020 in Hong Kong on January 15, which aims to become one of […]
December 27, 2019
The founder and CEO of the multinational hedge fund Citadel LLC, Ken Griffin remains unconvinced of BTC and its use cases. He […]
November 17, 2021
JD.com, one of the biggest Chinese e-commerce platforms, has purportedly enabled its customers to use the digital yuan for payments during the […]
November 17, 2021